RZLT Rezolute, Inc.
Healthcare$3.30+1.54%ClosedMarket Cap: $317.8M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
2.89
P/S
0.00
EV/EBITDA
-3.54
DCF Value
$1.15
FCF Yield
-23.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-58.8%
ROA
-64.9%
ROIC
-73.7%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 null | $0.00 | -Infinity% | $-17.4M | $-16.2M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-24.2M | $-22.8M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-19.8M | $-18.1M | $— | — |
| Q4 null | $0.00 | NaN% | $-25.9M | $-24.4M | $— | — |
| FY null | $0.00 | NaN% | $-79.9M | $-74.4M | $— | — |
| Q3 null | $0.00 | NaN% | $-20.0M | $-18.9M | $— | — |
| Q2 null | $0.00 | NaN% | $-17.1M | $-15.7M | $— | — |
| Q1 null | $0.00 | NaN% | $-16.9M | $-15.4M | $— | — |
| Q4 null | $0.00 | NaN% | $-23.1M | $-23.0M | $— | — |
| FY null | $0.00 | NaN% | $-70.4M | $-68.5M | $— | — |
| Q3 null | $0.00 | -Infinity% | $-16.2M | $-17.1M | $— | — |
| Q2 2024 | $0.00 | -Infinity% | $-15.2M | $-13.9M | $-0.27 | — |